Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8185237rdf:typepubmed:Citationlld:pubmed
pubmed-article:8185237lifeskim:mentionsumls-concept:C0002871lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C0014822lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C0333348lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:8185237lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:8185237pubmed:dateCreated1994-6-14lld:pubmed
pubmed-article:8185237pubmed:abstractTextIn patients with the anemia of chronic diseases, the plasma level of EPO is often low in relation to the blood hemoglobin concentration. Because infectious and inflammatory processes cause activation of cytokine-producing macrophages and lymphocytes, we investigated whether isolated inflammatory cytokines influence the synthesis of EPO in vitro. IL-1 and TNF-alpha were shown to inhibit EPO mRNA levels and EPO formation in the human hepatoma cell cultures HepG2 and Hep3B, and to lower EPO formation in isolated perfused rat kidneys. IFN-alpha and IFN-beta also induced some inhibition of EPO production in HepG2 cultures. IL-3, TGF-beta 2, and IFN-gamma did not inhibit. IL-6 stimulated the production of EPO in Hep3B cells but was ineffective in HepG2 cells and lowered EPO production in isolated perfused rat kidneys. IL-1, TNF-alpha, and possibly other cytokines could contribute to defective EPO production in renal and nonrenal immune responses.lld:pubmed
pubmed-article:8185237pubmed:languageenglld:pubmed
pubmed-article:8185237pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:citationSubsetIMlld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8185237pubmed:statusMEDLINElld:pubmed
pubmed-article:8185237pubmed:monthAprlld:pubmed
pubmed-article:8185237pubmed:issn0077-8923lld:pubmed
pubmed-article:8185237pubmed:authorpubmed-author:PagelHHlld:pubmed
pubmed-article:8185237pubmed:authorpubmed-author:FandreyJJlld:pubmed
pubmed-article:8185237pubmed:authorpubmed-author:JelkmannW EWElld:pubmed
pubmed-article:8185237pubmed:authorpubmed-author:FredeSSlld:pubmed
pubmed-article:8185237pubmed:issnTypePrintlld:pubmed
pubmed-article:8185237pubmed:day15lld:pubmed
pubmed-article:8185237pubmed:volume718lld:pubmed
pubmed-article:8185237pubmed:ownerNLMlld:pubmed
pubmed-article:8185237pubmed:authorsCompleteYlld:pubmed
pubmed-article:8185237pubmed:pagination300-9; discussion 309-11lld:pubmed
pubmed-article:8185237pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:meshHeadingpubmed-meshheading:8185237-...lld:pubmed
pubmed-article:8185237pubmed:year1994lld:pubmed
pubmed-article:8185237pubmed:articleTitleInhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states.lld:pubmed
pubmed-article:8185237pubmed:affiliationPhysiologisches Institut I, Universität Bonn, Germany.lld:pubmed
pubmed-article:8185237pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8185237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8185237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8185237lld:pubmed